AI assistant
Sending…
EXAGEN INC. — Director's Dealing 2023
Jul 26, 2023
33644_dirs_2023-07-26_ed2ed832-09b0-47e2-8a66-2d8f1883f334.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: EXAGEN INC. (XGN)
CIK: 0001274737
Period of Report: 2023-07-24
Reporting Person: Kim Paul (Director)
More from EXAGEN INC.
Share Issue/Capital Change
2026
May 12
Interim / Quarterly Report
2026
May 11
Earnings Release
2026
May 11
Annual Report
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Board/Management Information
2026
Apr 23
Director's Dealing
2026
Feb 25
Director's Dealing
2026
Feb 25
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 11